DarioHealth Corp. Common Stock (DRIO) is a publicly traded Healthcare sector company. As of May 21, 2026, DRIO trades at $8.13 with a market cap of $61.06M and a P/E ratio of 1.46. DRIO moved -2.44% today. Year to date, DRIO is -23.95%; over the trailing twelve months it is -39.39%. Its 52-week range spans $5.94 to $31.00. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces DRIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DarioHealth Q1 Revenue Up 24% to $14.8M, EBITDA Loss Narrows: DarioHealth’s Q1 revenue rose 24% year-over-year to $14.8 million, driven by a 28% increase in active subscribers to 95,000. Gross margin improved to 62%, narrowing the adjusted EBITDA loss to $1.9 million, while cash reserves of $48 million extend the runway into early 2027.
| Metric | Value |
|---|---|
| Price | $8.13 |
| Market Cap | $61.06M |
| P/E Ratio | 1.46 |
| EPS | $5.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.00 |
| 52-Week Low | $5.94 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.19M |
| Net Income | $-40.74M |
| Gross Margin | 56.55% |
2 analysts cover DRIO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.